356 related articles for article (PubMed ID: 24894717)
21. Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival.
Baumann F; Flores E; Napolitano A; Kanodia S; Taioli E; Pass H; Yang H; Carbone M
Carcinogenesis; 2015 Jan; 36(1):76-81. PubMed ID: 25380601
[TBL] [Abstract][Full Text] [Related]
22. A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma.
Wadt KA; Aoude LG; Johansson P; Solinas A; Pritchard A; Crainic O; Andersen MT; Kiilgaard JF; Heegaard S; Sunde L; Federspiel B; Madore J; Thompson JF; McCarthy SW; Goodwin A; Tsao H; Jönsson G; Busam K; Gupta R; Trent JM; Gerdes AM; Brown KM; Scolyer RA; Hayward NK
Clin Genet; 2015 Sep; 88(3):267-72. PubMed ID: 25225168
[TBL] [Abstract][Full Text] [Related]
23. Detecting germline BAP1 mutations in patients with peritoneal mesothelioma: benefits to patient and family members.
Kittaneh M; Berkelhammer C
J Transl Med; 2018 Jul; 16(1):194. PubMed ID: 30001711
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Germline versus Somatic BAP1 Mutations for Risk of Metastasis in Uveal Melanoma.
Ewens KG; Lalonde E; Richards-Yutz J; Shields CL; Ganguly A
BMC Cancer; 2018 Nov; 18(1):1172. PubMed ID: 30477459
[TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
[TBL] [Abstract][Full Text] [Related]
26. Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature.
Haugh AM; Njauw CN; Bubley JA; Verzì AE; Zhang B; Kudalkar E; VandenBoom T; Walton K; Swick BL; Kumar R; Rana HQ; Cochrane S; McCormick SR; Shea CR; Tsao H; Gerami P
JAMA Dermatol; 2017 Oct; 153(10):999-1006. PubMed ID: 28793149
[TBL] [Abstract][Full Text] [Related]
27. Roles of the BAP1 Tumor Suppressor in Cell Metabolism.
Han A; Purwin TJ; Aplin AE
Cancer Res; 2021 Jun; 81(11):2807-2814. PubMed ID: 33446574
[TBL] [Abstract][Full Text] [Related]
28. BAP1: Not just a BRCA1-associated protein.
Louie BH; Kurzrock R
Cancer Treat Rev; 2020 Nov; 90():102091. PubMed ID: 32877777
[TBL] [Abstract][Full Text] [Related]
29. Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma.
Sneddon S; Leon JS; Dick IM; Cadby G; Olsen N; Brims F; Allcock RJ; Moses EK; Melton PE; de Klerk N; Musk AW; Robinson BW; Creaney J
Gene; 2015 May; 563(1):103-5. PubMed ID: 25796603
[TBL] [Abstract][Full Text] [Related]
30. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations.
Gupta MP; Lane AM; DeAngelis MM; Mayne K; Crabtree M; Gragoudas ES; Kim IK
JAMA Ophthalmol; 2015 Aug; 133(8):881-7. PubMed ID: 25974357
[TBL] [Abstract][Full Text] [Related]
31. Analysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma Patients.
Cebulla CM; Binkley EM; Pilarski R; Massengill JB; Rai K; Liebner DA; Marino MJ; Singh AD; Abdel-Rahman MH
Ophthalmic Genet; 2015 Jun; 36(2):126-31. PubMed ID: 25687217
[TBL] [Abstract][Full Text] [Related]
32. Histomorphologic spectrum of germline-related and sporadic BAP1-inactivated melanocytic tumors.
Garfield EM; Walton KE; Quan VL; VandenBoom T; Zhang B; Kong BY; Isales MC; Panah E; Kim G; Gerami P
J Am Acad Dermatol; 2018 Sep; 79(3):525-534. PubMed ID: 29753057
[TBL] [Abstract][Full Text] [Related]
33. Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations.
Kadariya Y; Cheung M; Xu J; Pei J; Sementino E; Menges CW; Cai KQ; Rauscher FJ; Klein-Szanto AJ; Testa JR
Cancer Res; 2016 May; 76(9):2836-44. PubMed ID: 26896281
[TBL] [Abstract][Full Text] [Related]
34. Proteomic analysis identifies novel binding partners of BAP1.
Baas R; J van der Wal F; Bleijerveld OB; van Attikum H; Sixma TK
PLoS One; 2021; 16(9):e0257688. PubMed ID: 34591877
[TBL] [Abstract][Full Text] [Related]
35. BRCA1-associated protein 1 deficiency in lung adenocarcinoma predicts poor outcome and increased tumor invasion.
Shen C; Wang Y; Wei P; Du X
BMC Cancer; 2016 Aug; 16(1):670. PubMed ID: 27553041
[TBL] [Abstract][Full Text] [Related]
36. BAP1 regulates IP3R3-mediated Ca
Bononi A; Giorgi C; Patergnani S; Larson D; Verbruggen K; Tanji M; Pellegrini L; Signorato V; Olivetto F; Pastorino S; Nasu M; Napolitano A; Gaudino G; Morris P; Sakamoto G; Ferris LK; Danese A; Raimondi A; Tacchetti C; Kuchay S; Pass HI; Affar EB; Yang H; Pinton P; Carbone M
Nature; 2017 Jun; 546(7659):549-553. PubMed ID: 28614305
[TBL] [Abstract][Full Text] [Related]
37. Loss of the deubiquitylase BAP1 alters class I histone deacetylase expression and sensitivity of mesothelioma cells to HDAC inhibitors.
Sacco JJ; Kenyani J; Butt Z; Carter R; Chew HY; Cheeseman LP; Darling S; Denny M; Urbé S; Clague MJ; Coulson JM
Oncotarget; 2015 May; 6(15):13757-71. PubMed ID: 25970771
[TBL] [Abstract][Full Text] [Related]
38. CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma.
Betti M; Aspesi A; Biasi A; Casalone E; Ferrante D; Ogliara P; Gironi LC; Giorgione R; Farinelli P; Grosso F; Libener R; Rosato S; Turchetti D; Maffè A; Casadio C; Ascoli V; Dianzani C; Colombo E; Piccolini E; Pavesi M; Miccoli S; Mirabelli D; Bracco C; Righi L; Boldorini R; Papotti M; Matullo G; Magnani C; Pasini B; Dianzani I
Cancer Lett; 2016 Aug; 378(2):120-30. PubMed ID: 27181379
[TBL] [Abstract][Full Text] [Related]
39. Targeting BAP1: a new paradigm for mesothelioma.
Schunselaar LM; Zwart W; Baas P
Lung Cancer; 2017 Jul; 109():145-146. PubMed ID: 28342657
[TBL] [Abstract][Full Text] [Related]
40. Germline BAP1 mutations predispose also to multiple basal cell carcinomas.
de la Fouchardière A; Cabaret O; Savin L; Combemale P; Schvartz H; Penet C; Bonadona V; Soufir N; Bressac-de Paillerets B
Clin Genet; 2015 Sep; 88(3):273-7. PubMed ID: 25080371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]